Product Information

DEXMETHYLPHENIDATE ER 35 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0932 per EA under NDC 00093504601. Its NADAC has been published 401 times since Dec 19, 2018.

FDA first approved this application on Nov 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXMETHYLPHENIDATE ER 35 MG CP

Dexmethylphenidate Hydrochloride
$2.0932per EA
DEA Schedule CII

Strength

35 mg/1

NDC

00093504601

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202731

FDA Approved

11/19/2013

TE Code

AB

On Market Since

7/5/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has been published 401 times since Dec 19, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$2.0932 per EA
All-time high$3.7935 (Jul 10, 2019)
All-time low$1.1390 (Dec 21, 2022)
52-week high$2.5971
52-week low$1.9329
Median price$2.4436
Average price$2.4021
Largest weekly change+55.4% (Apr 26, 2023)
Weeks tracked401
Tracking sinceDec 19, 2018

Price History

1W

-0.5%

1M

-0.5%

3M

+8.3%

6M

-14.5%

1Y

-12.4%

3Y

-14.3%

5Y

-22.2%

All

-1.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DEXMETHYLPHENIDATE ER 35 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 35 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $2.0932 per EA (NDC 00093504601), effective Aug 19, 2026.

How has the price of DEXMETHYLPHENIDATE ER 35 MG CP changed over time?

Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has held within roughly two percent of its current level. It has been tracked across 401 weekly CMS publications since Dec 19, 2018.

What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 35 MG CP?

Since Dec 19, 2018, the NADAC for DEXMETHYLPHENIDATE ER 35 MG CP has ranged from a low of $1.1390 (Dec 21, 2022) to a high of $3.7935 (Jul 10, 2019), with a median of $2.4436 per EA.

Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 35 MG CP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 35 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXMETHYLPHENIDATE ER 35 MG CP?

DEXMETHYLPHENIDATE ER 35 MG CP (NDC 00093504601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.